Evidence map›Paper›PMID 39168910›Full record

ArticleAnnals of hematology2024

Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.

Vanda Strafella, Immacolata Attolico, Paola Carluccio, Francesco Tarantini, Paola Curci, Nicola Sgherza, Rita Rizzi, Angelo Ostuni, Gabriele Buda, Maria Livia Del Giudice and 15 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Vanda StrafellaDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.
Immacolata AttolicoUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
Paola CarluccioUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
Francesco TarantiniDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.
Paola CurciUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
Nicola SgherzaUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
Rita RizziDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.
Angelo OstuniUnit of Transfusion Medicine, AOUC Policlinico, Bari, Italy.
Gabriele BudaHaematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Maria Livia Del GiudiceHaematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Vincenzo MarascoDivision of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milan, Italy.
Anna MeleDepartment of Hematology and Bone Marrow Transplant, Hospital Card. G. Panico, Tricase, Italy.
Gloria Margiotta-CasaluciDivision of Hematology, Department of Translational Medicine, AOU Maggiore della Carità, Novara, Italy.
Viviana Beatrice ValliHaematology Unit, ASST Ovest Milanese Legnano Hospital, Legnano, Italy.
Giuseppe MeleHaematology and Transplant Unit, Ospedale Antonio Perrino, Brindisi, Italy.
Candida Rosaria GermanoHaematology and Transplant Unit, Ospedale Monsignor R. Dimiccoli, Barletta, Italy.
Angela Maria QuintoHaematology and Transplant Unit, IRCCS - Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Giulia PalazzoHaematology and Transplant Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
Massimiliano Arangio FebboOnco-Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Lucia CiuffredaHaematology and Transplant Unit, Ospedali Riuniti, Foggia, Italy.
Giovanni ReddicontoHaematology and Transplant Unit, Vito Fazzi Hospital, Lecce, Italy.
Nicola Di RenzoHaematology and Transplant Unit, Vito Fazzi Hospital, Lecce, Italy.
Michele CimminielloDivision of Hematology, Ospedale "San Carlo", Potenza, Italy.
Francesco AlbanoDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.
Pellegrino MustoDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy. pellegrino.musto@uniba.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39168910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.